Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects.
about
EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas.Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinomaDiagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia.Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for fieThe distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer typesTwo-step Epstein-Barr virus immunoglobulin A enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinomaBead arrays for antibody and complement profiling reveal joint contribution of antibody isotypes to C3 deposition.Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients.Humoral immune responses to Epstein-Barr virus encoded tumor associated proteins and their putative extracellular domains in nasopharyngeal carcinoma patients and regional controls.Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinomaShort-term effect of different teaching methods on nasopharyngeal carcinoma for general practitioners in Jakarta, IndonesiaPrimary treatment results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, Indonesia.Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray.Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study.Can Epstein-Barr virus DNA load in nasopharyngeal brushings or whole blood predict recurrent nasopharyngeal carcinoma in a non-endemic region? A prospective nationwide study of the Dutch Head and Neck Oncology Cooperative Group.Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families.Serum antibody response to lytic and latent Epstein-Barr virus antigens in undifferentiated nasopharyngeal carcinoma patients from an area of nonendemicityWTC-01, a novel synthetic oxime-flavone compound, destabilizes microtubules in human nasopharyngeal carcinoma cells in vitro and in vivo.Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor originThe "Bridge" in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infection.Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.Dried-blood sampling for epstein-barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening.Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinoma.Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma.Expression of interleukin-8, interleukin-10 and Epstein-Barr viral-load as prognostic indicator in nasopharyngeal carcinoma.Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to Toll-like receptor 3-mediated apoptosisEvaluation of a multianalyte profiling assay and an enzyme-linked immunosorbent assay for serological examination of Epstein-Barr virus-specific antibody responses in diagnosis of nasopharyngeal carcinoma.Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers detected by xMAP technology.The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function.Seroprevalence of IgA anti Epstein-Barr virus is high among family members of nasopharyngeal cancer patients and individuals presenting with chronic complaints in head and neck area.Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle.An efficacy analysis for nasopharyngeal carcinoma screening of different screening intervals.Establishment and validation of a two-step screening scheme for improved performance of serological screening of nasopharyngeal carcinoma.
P2860
Q24804219-5733C36D-4708-4DB4-A64F-C554877644BBQ27016002-779FD603-E0C8-468B-9972-0816CEEAA65BQ33218405-A60D93DE-3D79-48FE-B151-A2D131EDA394Q33239049-004824B8-6205-4721-8C49-ED3EAA73F6B5Q33389641-2E866E3C-1224-46DD-8C21-E7F2286B9FD0Q33422245-BF4E5686-EC25-4752-A35F-D4DF0FE1324FQ33568195-07AF5C83-8468-40C2-8A40-F9F6D193A1D9Q33760249-E1EE596D-E638-4972-B0D7-A2FFDFCC1E57Q33822681-41121E93-F19B-474D-BCD4-10ADC03FDB1DQ34173615-63CC7287-DDE4-401E-8D8E-141376D78DB8Q34202771-69844001-9D46-48EF-91E4-4613085538C2Q34722985-868073C0-274A-4581-9B3D-FCF85FA8E2E5Q35093052-503783EB-045E-4DF4-A8C5-1663D67B4457Q35463816-3E76DB94-69A5-4AC8-8CEC-9293B3E6E3A6Q35599997-30C82AA2-D062-4ADB-86A7-A280D8EDA736Q35619542-6C531783-C2C0-4293-8B31-456DA4CC252AQ35709503-0A56BEC6-867C-4DD0-8550-A2E241EB1A49Q35783467-E2A62A9C-48BA-4384-A1FB-A6827D66FB01Q36124216-D000D4F2-8691-4F76-9CC4-BFE0067D410EQ36124331-2EF4592B-E549-441C-9FD2-44C3D9470DA6Q36154936-DA3D887D-F0F6-4B14-A77F-7397FDD3D444Q36399124-4F234685-8BF7-48F7-9942-5CFE0124B5EBQ36539838-988F0D82-9D70-4ED1-9345-0D677390D3CFQ36557221-1E4133EF-3D75-4528-89DB-E1AA815F9C98Q36609904-8C1FC48B-6153-43F9-B4D0-51A7DA850DACQ36713194-EAA5B934-3927-4CAE-B103-85572E4E201FQ36944175-1A8EDD5F-F1D3-437D-97C2-CB4877E32209Q36974327-39327B57-FE94-4D87-94BC-370B18149ACDQ37325545-A2B4DB2B-7355-4BAD-86DB-D600F057D321Q40033016-470942DA-D3A1-43CD-9805-92CAD633CD93Q40085909-9B235401-4ACA-4495-8206-B6A447DD75B0Q41807836-E68CB2D1-B88F-478D-A05B-9587D01DD466Q51184991-E84CE740-FBCC-4E98-8E7D-BB2BBB87D46FQ52685801-16B8AF29-3E0D-4944-B888-AD95ABDDEB45
P2860
Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Molecular diversity of Epstein ...... hinese, and European subjects.
@ast
Molecular diversity of Epstein ...... hinese, and European subjects.
@en
type
label
Molecular diversity of Epstein ...... hinese, and European subjects.
@ast
Molecular diversity of Epstein ...... hinese, and European subjects.
@en
prefLabel
Molecular diversity of Epstein ...... hinese, and European subjects.
@ast
Molecular diversity of Epstein ...... hinese, and European subjects.
@en
P2093
P921
P356
P1476
Molecular diversity of Epstein ...... hinese, and European subjects.
@en
P2093
Ahmad Harijadi
Bambang Hariwiyanto
Dewi K Paramita
Jaap M Middeldorp
Jajah Fachiroh
Sofia M Haryana
Tabitha Schouten
P356
10.1086/421245
P407
P577
2004-05-26T00:00:00Z